Central banking of hybridomas

Area of Science:

• Immunology
• Biotechnology

Background:

• Hybridoma technology enables the production of monoclonal antibodies.
• A wide diversity of hybridoma cell lines exists due to antibody diversity.
• Commercial interests are increasingly involved in monoclonal antibody production.

Purpose of the Study:

• To establish a central facility for hybridoma cell line management.
• To facilitate the exchange and preservation of valuable hybridoma cell lines.
• To support the growing field of monoclonal antibody research and application.

Main Methods:

• Collaboration between the National Institute of Allergy and Infectious Diseases and the American Type Culture Collection.
• Development of a centralized system for cell line acquisition.
• Implementation of protocols for cell line maintenance and distribution.

Main Results:

• A central facility is being developed for hybridoma cell lines.
• The facility will manage acquisition, maintenance, and distribution.
• This infrastructure supports the exchange and preservation of diverse cell lines.

Conclusions:

• A centralized hybridoma cell line facility is necessary.
• This initiative will aid researchers by providing access to diverse cell lines.
• The facility will help preserve important cell lines for future use.